• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
12.05.2022
Perspective ETFs in the ESG energy segment: Invesco Global Clean Energy Portfolio ETF

This ETF invests in green energy ventures. The pandemic led to a 300% increase of its share price. But since the beginning of 2022 they have lost 30%, twice as much as the S&P 500 SPY ETF. The net capital which has outflown from the Fund has reached $31.5 billion over the last 12 months, while the major outflow was recorded in December 2021. However, its shares are still seen to be overbought as P/E multiplier is at 24 that is well above the average of 20 for the EFT’s that are linked to the S&P 500, while the dividend yields are above PBD’s numbers.

Inflation in the United States is rising negatively affecting all shares with a high P/E ratio. So, we may expect a further decline of the PBD share price and other similar assets that cannot be protected from rising risks. Traditional energies are looking more attractive on this background and could be a perfect hedge asset amidst geopolitical uncertainties. 

12.04.2024
CarMax Is More Committed to Innovations But Market Conditions Make It Sinking

CarMax (KMX) quarterly report came out on April 11, vividly displaying why any immediate investment into the used car market still sounds like not a good idea. The stock quickly lost ground, wasting a double-digit number of percentage points as a response to its net income drop to $0.32 per share against $0.44 cents per share a year ago, also compared to much stronger $0.52, $0.75 and $1.44 per share in the previous three quarters. Analyst polls estimated a net income per share at about $0.50, which would be 56% better than the reality.

This almost looks like a financial fiasco in the company's efforts to withstand slowing demand in the segment. CarMax Q4 2023 revenue decreased by 1.7% to $5.6 billion, slightly below consensus expectations of $5.8 billion, indicating the lack of gross marginality of the business. This happened even though the total supply of unsold used vehicles on dealer lots grew by 9% YoY to 2.27 million units in March, according to Cox Automotive data. CarMax CEOs delayed their own goal of selling over 2 million units annually, when measuring combined retail and wholesale actions, to between 2026 and 2030, from its prior target of 2026.

A "higher-for-longer" Fed fund rates is demonstrably bad for car sales volumes, be it new generation Tesla cars or just pre-owned vehicles, while operating costs for warehouses are growing. Besides, easing some semiconductor constraints in North America may help marginally improving orders for new cars, leaving used-car sales under the same pressure. Meanwhile, the entrance of Asia players offered significant discounts. Therefore, North American and European operators of the used car market need to sell many great cars at cheaper prices. CarMax already posted its official warning of a potential "hit to profit-sharing revenue" due to inflationary impact to its partners, before last Christmas. "While affordability of used cars remains the challenge for consumers, pricing improved during the quarter," Enrique Mayor-Mora, executive vice president and CFO admitted.

It was only a smaller division of CarMax Auto Finance, which managed to get a 19% better income due to "a lower provision for loan losses" and an increase in average managed receivables. Yet, this was rather news from the side business, which was clearly not enough to be optimistic. The company added that it is now focused on enhancing its omni-channel experience and leveraging data science and automation. Carmax said it delivered "strong retail and wholesale" graphic processors, which helped to increase "used saleable inventory units" more than 10%, but used total inventory units was unchanged despite innovations. The company seeks to achieve efficiency improvements in its core operations, believing that they "are well-positioned to drive growth as the market turns", according to Enrique Mayor-Mora. This may be useful to strengthen competitiveness in better times for the segment. Yet, the current challenges are too heavy to be ignored by market crowds.

16.06.2022
Not Every Tech Stocks are Equally Strong: SAP

SAP stocks have lost 30% since the beginning of 2022. The German tech company develops enterprise software and solutions to manage business operations. For example, one of its services can be used  to manage all business travel financial activities and related spending. In other words, it is quite a routine company with  a stable and strong cash flow. Once SAP software is installed on a corporate level it is hard to do without it as it is deeply integrated into the business core processes. Moreover, SAP is restructuring its business model around its subscription base and this will allow for cash flows to be even more predictable and balanced through the financial year. Such a model is in favourable to Wall Streel investors.

The war in Ukraine has a 300-million-euro negative effect on SAP business, and it is only a marginal 1% of the overall revenue base for the company, while its dominance in the ERP segment is secure. The revenues added 11% year-on-year to 7.08 euros in Q1 2022. The revenues grew by 6% in  Q4 2021.

The company has made some successful M&A deals, acquiring Qualtrics, a cloud-based subscription software platform, that delivered +48% revenue in Q1 2022. This company had a gross margin above 90% in 2021 while SAP’s gross margin was at 70% for the same year.

SAP management promised to triple its cloud-based business by 2025, and boost revenues to 22 billion euros, while operational profit is forecasted to grow by 40% from the current 8.4 billion euros. This is a very extensive growth for the company that has a high P/E ratio at 17. The company may not perform very high growth rates as its younger tech sector peers, but it may certainly recover to new all-time highs in the long-term perspective. However, the sector may require several quarters to recover, and the recovery would be headed by such reliable companies as SAP with a low risk profile.

15.09.2022
Safe Haven Assets for Long-Term Investments: Broadcom

Broadcom is an American semiconductor and infrastructure software development company. Soon it is expected to close a merger deal with VMware, a cloud computing and visualization company, that will open new cross-sales opportunities for Broadcom to boost its revenues. Broadcom stocks are now 25% off their peak values.

According to the Q3 FY 2022 financial report that ended July 31, consolidated revenues grew by 25% year-over-year to $8.46 billion, and EPS went up by 40% to $9.73 per share. The semiconductors segment, that added 32% year-over-year, was the primary driver for the company’s profit. The company’s free cash flows (FCF) topped $4.3 billion, allowing it to spend $1.7 billion on dividends and 1.5 billion on the shares repurchase program. The company is planning to continue spending at least 50% of FCF on dividends that added 43% every year on average since 2016. 

According to the Q4 FY 2022 forward guidance, the company is expecting its revenues to go up by 20% year-over-year to $8.9 billion and for EDITDA to go up by 25% to $5.6 billion. Broadcom has great experience in expanding its product portfolio by M&A operations, and apparently it will continue on this way. The company is also expected to benefit greatly from the $52.7 billion CHIPS bill in the United States.


11.08.2022
Perspective Peers of Ethereum: Avalanche

Avalanche is ranked by Coinmarketcap at the 12th position by market cap with $7.8 billion, which is 4% less than Ethereum’s market cap. AVAX prices dropped by 82% of its peak values, allowing investors to buy it at early 2021 prices. Avalanche’s infrastructure consists of three logically isolated networks, each of these with their own processing, validators, and own set of rules.

This platform is often compared to the existing internet web infrastructure with core connection protocols like HTTP, surrounded by a huge number of networks to their apps. Avalanche allow for the creation of public and private systems as a blockchain or DAG (Directed Acyclic Graph) and for the use of different virtual machines for apps, including EVM engine (Ethereum Virtual Machine) that allows Enthereum network programs to be developed.

Avalanche includes C-chain to create smart contracts that are processed on an advanced EVM engine, P-Chain that coordinates validators that process transactions and also allows for the creation and management of new subnetworks, and X-Chain which is a directed acyclic graph regulating issuance and trade of cryptoassets. DAG systems record new transactions on top of the old ones, allowing for processing speed to be increased and for capacity substantially. It is quite different to other blockchains, where transactions are compiled in blocks in order to be processed.

The advantage of Avalanche is that it provides anyone with the opportunity to create his or her own isolated blockchain with its own set of parameters, including access to apps and the programming language with which it will work. Every subnetwork can process around 4,500 transactions per second compared to 14 processed by the Ethereum network.

B
Another Unicorn Is Charging

Tesla is trading above $420 today! Rising by as much as 20%, or $70 compared to the opening price of around $350 per share just three business days ago, at the pre-market on September 11. Taking summer consolidation lows for bigger long bets has borne many sweet fruits.

You know, I was among those Tesla optimist campers who vowed sleeplessly and loudly enough about an inevitable move well beyond a multi-month $350 barrier soon. Meanwhile, the area of $420 has been considered by many enthusiasts, including me, as the first likely mid-term target. And I keep my next price target for another half of my personal stake in Tesla just a bit above $500, valid for late 2025 or early 2026. However, this mark of $420 deserves at least half of the profit-taking volume. Surely, not only because it is one of Elon Musk's favourite numbers, inextricably linked to the pot culture he aimed at in his very old tweets years ago. The point is that the mark was also reached too quickly right at the moment. If we had been climbing here gradually for several weeks, I wouldn't even have looked back at this step only to take a breath, but now the horny crowd produced a kind of too volatile scenario.

While I understand Tesla as a very real and powerful value as a giant business not just in the segment of cutting-edge electric cars and also parts and gas stations for them, but as a pioneer in AI robotics, I'm a little put off by the overly lightweight reasons behind the stock's recent rise.

In an interview with Bloomberg TV last Friday morning, Tesla board chair Robyn Denholm clearly dismissed all those quite common misconceptions that Elon Musk’s political activity had allegedly depressed Tesla sales globally. She called the eccentric multi billionaire as "front and center" at the company after he resigned from his temporary job at the White House. "What he does from a personal perspective in terms of his political motivations is up to him," she added as "obviously we’re in a democracy, so everyone gets to voice their points of view". Robyn Denholm delivered all those comments just days after Tesla’s board officially launched a $1 trillion "compensation plan" for CEO Elon Musk, in what would be the largest corporate pay package in history. Denholm admitted there’s some investor fatigue around the matter of Musk’s previous controversial 2018 pay plan of roughly $50 billion, still nominally tied up in a Delaware court. But she thinks the latest $1 trillion proposal is what investors want, even despite the Cybertruck, launched in 2023, is still not in the sales top while Tesla's pretentious bet on robot cars' wide distribution all over the world is still in its infancy with a limited taxi service in Texas. “Our view is the opportunity ahead is far greater with Elon at the helm than without,” she emphasized.

Well, Musk’s ambitions into party politics heightened concerns among Tesla investors. The board has recommended shareholders, during its annual meeting, to vote against a radical proposal on political neutrality, which could prohibit the company's team from endorsing any political party. This will not hurt sales, the board chair said, but without mentioning new figures. That's very good, but many were wondering if that was enough for a 7.5% price move to the upside in one day on September 12. The genuine background behind the move was revealed today, after a regulatory filing showed that Elon Musk himself had purchased nearly $1 billion worth of Tesla stock in the course of that Friday's session. Before this, Musk held a roughly 13% stake in Tesla, and this Monday he disclosed additional buying of 2.57 million Tesla shares in open-market transactions on Friday. He paid between $372.37 and $396.54 per one item, showing much confidence in the further price growth. That's why last Friday's move was so fast, as many investors eagerly joined Mask-initiated rise. And Tesla shares jumped up to another 8% on Monday, because of the same news on Musk's purchase. What a cool way to move a stock price up and then hit the Repeat button just by talking about it! Gorgeous, I'm enchanted! He already earned much money by spending $1 billion only, out of this future $1 trillion income, and he also increased his share at Tesla.

Before that, Musk threatened to build AI and robotics products somewhere outside of Tesla if he cannot get 25% voting power. Now his strategy is clearer to do this inside the Tesla company, and he will surely not sell his stake at $420 or even above $500. But I am a small investor to earn my little money, and I will take some profit here at $420 and hope to repeat this successful action somewhere above $500 as well some time later.

1120
Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
Harmony Is Seen Rallying to $0.0150

Harmony (ONE) is down 4.3% to $0.0104 this week, underperforming Bitcoin (BTC), which slipped 1.0% to $114,978. The token is once again testing the strong $0.0100 support that has held since January 2021. Over the past five months, prices have consolidated in a narrowing range around this level, a pattern that typically precedes a strong breakout. Given the proximity to firm support, the move is more likely to the upside, with $0.0150 as the key resistance target. The Federal Reserve’s upcoming decision could act as the trigger for such a move.

1140
AbbVie Has More Room for Appreciation

Shares of AbbVie pharmaceuticals hit an all-time record this week. This nearly $400 billion capitalized stock closed at $220.22 on September 11, up 4% from the previous day's performance, with an intraday high being at $221.76. The rise of the pharma sector is not as impressive as for so many cases in AI industry. On average, this process could be called rather restorative, even for big pharma stocks, but Abbvie as a real giant of the sector is a pleasant exception, having added about 30% from April's local lows corresponding to the tariff storm. And it has room for additional appreciation by market crowds and experts in the nearest 6 weeks before its scheduled quarterly earnings call on October 24.

Historically, Humira prescription drug to reduce the signs and symptoms of moderate to severe rheumatoid arthritis has been the crown jewel of AbbVie's commercial success, with its annual revenue reaching extraordinary heights around $20 billion globally. This was once Abbvie's best-selling drug, now battling severe competition from cheaper biosimilars produced by rivals since 2023. It has been reported in the mid-week, however, that no generic competition for Abbvie's currently blockbuster immunology drug Rinvoq used for similar diseases could be seen until 2037 at least. Again, the settlement with largest generic makers, which is subject to certain provisions in the U.S., is going to prevent sales erosion of Rinvoq within this 12-year timeframe, marking a 4-year extension compared to previous public estimates. Chris Schott at JP Morgan & Chase said the extension for its Rinvoq franchise gives AbbVie "years of runway on one of its key growth drivers" develop and test more now-experimental drugs ahead of any potential loss of exclusivity in the mid-2030s.

Humira is a biologic that blocks the so-called TNF (tumor necrosis factor), while Rinvoq scientifically is a JAK (Janus kinase) inhibitor that works inside cells to block signals causing inflammation. They also differ in how they are administered as Humira is an injection, whereas Rinvoq is a daily oral tablet. Rinvoq is also being tested for diseases such as alopecia areata, vitiligo, hidradenitis suppurativa and systemic lupus erythematosus. Rinvoq's annual sales for 2024 were $5.97 billion, a 46% increase from the prior year, while its Q2 2025 sales already reached $2.028 billion, another 41.8% of remarkable surplus YoY, accounting for more than 10% of total Abbvie sales. The figures contribute much to AbbVie's overall sales, with the combined sales of $15.42 billion in Q2 2025, with Rinvoq and Skyrizi projected to exceed $31 billion together by as early as 2027. Skyrizi is a brand name for a biologic injection to treat plaque psoriasis, its net sales reached $11.7 billion in 2024, a more than 50% increase vs 2023, and generated $4.4 billion only in the previous quarter to marking a 62% increase on an annual basis QoQ.

For us, the "fair value" of Abbvie could be estimated within the range of between $235 and $250 per share. We will wait and see when the opinion of the market crowd joins these reasonable estimates. This may happen before the end of this year or later in the spring of 2026, depending on investors' immediate response to the quarterly report in late October.

1243
Rafael Quintana Martinez
Money Manager de alto rendimiento, con una sólida formación académica, profesional y de campo. Más de 9 años de experiencia especializada en el comercio de mercados financieros internacionales. La devoción, la fiabilidad, la responsabilidad y la ética impulsan mi vida. Actualmente me desempeño como Analista Senior para Metadoro. https://metadoro.com/es https://mx.investing.com/members/contributors/235587671/ https://es.tradingview.com/chart/EURUSD/rE9gVips/
Litecoin Is Struggling to Push Higher

Litecoin (LTC) is adding 1.5% to $115.74 this week, underperforming Bitcoin (BTC), which is rising by 3.4% to $114,487. LTC could be preparing for stronger moves as the SEC decision on a spot LTC-ETF approaches in October. Such approvals typically attract institutional investors and increase liquidity. Expectations of a dovish Fed stance may also support momentum. However, the token remains capped by the uptrend resistance at $125–126, which it unsuccessfully attempted to break in August. The nearest target is $120, and a decisive move above that level could open the way towards $140.

1139
13

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors